![]() listing by a Chinese firm on record, after Alibaba Group Holding Ltd.’s $25 billion blockbuster debut in 2014. this year, according to data compiled by Bloomberg. Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte. The ride-hailing firm’s IPO price was set at 14 per share, raising at least 4.4 billion, and closed up 15.98 to reach 16.4 the next day, with a market value of 78.6 billion. LinkDoc, founded in 2014, provides cancer-focused health care services built on big data and artificial intelligence, according to its IPO prospectus. ![]() ![]() Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte according to a preliminary filing.Ĭhinese companies have raised about $13 billion through first-time share sales in the U.S. Pandaily previously reported that Didi was officially listed on the NYSE on the evening of June 30, under ticker symbol DIDI. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. A representative for LinkDoc declined to comment. Reuters reported LinkDoc’s IPO halt earlier Thursday. LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese company from listing overseas even if the unit selling shares is incorporated outside China, closing a loophole long-used by the country’s technology giants, Bloomberg News reported this week. plunged after the government ordered the removal of the ride-hailing giant’s app from local app stores within days of its $4.4 billion U.S. Didi keep ximalaya linkdoc us ipotimes professional. were arranging the deal.Ĭhinese technology stocks suffered a rout after China signaled a new era of tighter oversight over cybersecurity. Regulations being rolled out that could see Chinese companies delisted if they do not comply with U.S. View source version on businesswire.LinkDoc's decision to suspend its 211 million IPO, first reported by Reuters, is likely to be followed by others, analysts said, although they noted that U.S. LinkDoc was slated to price the offering on Thursday, which could have raised as much as $211 million. Market volatility has played a part in the postponement and the Beijing-based medical data company could revisit its listing plans when conditions improve, said one of the people, who asked not to be identified as the information is private. initial public offering, people familiar with the matter said, the first known company to pull out of a debut after China’s government cracked down on overseas listings.
0 Comments
Leave a Reply. |